Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
$IKT what do you make of this data? | conix | investorshub | 04/03/2023 7:48:05 AM |
are we finally gonna see some action | CarlCarlMcB | investorshub | 04/03/2023 1:09:08 AM |
$IKT just the news we needed | heyitsmeagain | investorshub | 04/02/2023 7:48:52 PM |
The gaining last trade up | jedijazz | investorshub | 04/02/2023 7:37:04 PM |
best news of the day | conix | investorshub | 04/02/2023 2:48:17 PM |
best news of the day | conix | investorshub | 04/02/2023 12:45:35 PM |
The gaining | conix | investorshub | 04/02/2023 9:43:54 AM |
MomentumIts now | ProfitScout | investorshub | 04/02/2023 7:29:21 AM |
$IKT and the shorts continue | PennyPusher786 | investorshub | 04/02/2023 5:44:21 AM |
$IKT The gaining | conix | investorshub | 04/02/2023 4:43:08 AM |
$IKT oh yeah news for the day | conix | investorshub | 04/01/2023 6:51:48 PM |
good read | ProfitScout | investorshub | 04/01/2023 6:09:07 PM |
$IKT The now | conix | investorshub | 04/01/2023 12:52:48 PM |
is it bear time? Or do we go bull? | conix | investorshub | 04/01/2023 6:44:02 AM |
short squeeze signal | conix | investorshub | 04/01/2023 3:18:47 AM |
must see | heyitsmeagain | investorshub | 04/01/2023 12:14:02 AM |
Price trading last trade up | conix | investorshub | 03/31/2023 9:35:00 PM |
$IKT Price now | ProfitScout | investorshub | 03/31/2023 6:21:37 PM |
$IKT Price now last up | conix | investorshub | 03/31/2023 5:39:55 PM |
Price trading | jedijazz | investorshub | 03/31/2023 2:33:23 PM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...